• Something wrong with this record ?

Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis

Y. Kochi, Y. Kamatani, Y. Kondo, A. Suzuki, E. Kawakami, R. Hiwa, Y. Momozawa, M. Fujimoto, M. Jinnin, Y. Tanaka, T. Kanda, RG. Cooper, H. Chinoy, S. Rothwell, JA. Lamb, J. Vencovský, H. Mann, K. Ohmura, K. Myouzen, K. Ishigaki, R. Nakashima, Y....

. 2018 ; 77 (4) : 602-611. [pub] 20180113

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

OBJECTIVES: Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of rare autoimmune diseases in which both genetic and environmental factors play important roles. To identify genetic factors of IIM including polymyositis, dermatomyositis (DM) and clinically amyopathic DM (CADM), we performed the first genome-wide association study for IIM in an Asian population. METHODS: We genotyped and tested 496 819 single nucleotide polymorphism for association using 576 patients with IIM and 6270 control subjects. We also examined the causal mechanism of disease-associated variants by in silico analyses using publicly available data sets as well as by in in vitro analyses using reporter assays and apoptosis assays. RESULTS: We identified a variant in WDFY4 that was significantly associated with CADM (rs7919656; OR=3.87; P=1.5×10-8). This variant had a cis-splicing quantitative trait locus (QTL) effect for a truncated WDFY4isoform (tr-WDFY4), with higher expression in the risk allele. Transexpression QTL analysis of this variant showed a positive correlation with the expression of NF-κB associated genes. Furthermore, we demonstrated that both WDFY4 and tr-WDFY4 interacted with pattern recognition receptors such as TLR3, TLR4, TLR9 and MDA5 and augmented the NF-κB activation by these receptors. WDFY4 isoforms also enhanced MDA5-induced apoptosis to a greater extent in the tr-WDFY4-transfected cells. CONCLUSIONS: As CADM is characterised by the appearance of anti-MDA5 autoantibodies and severe lung inflammation, the WDFY4 variant may play a critical role in the pathogenesis of CADM.

Department of Allergy and Rheumatology Graduate School of Medicine the University of Tokyo Tokyo Japan

Department of Dermatology and Plastic Surgery Faculty of Life Sciences Kumamoto University Kumamoto Japan

Department of Dermatology Faculty of Medicine Institute of Medical Pharmaceutical and Health Sciences Kanazawa University Kanazawa Japan Department of Dermatology University of Tsukuba Ibaraki Japan

Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan

Department of Hematology and Immunology Kanazawa Medical University Ishikawa Japan

Department of Immunology and Rheumatology Unit of Advanced Preventive Medical Sciences Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

Department of Internal Medicine and Rheumatology Juntendo University School of Medicine Tokyo Japan

Department of Internal Medicine Faculty of Medicine University of Tsukuba Tsukuba Japan

Department of Neurology and Clinical Neuroscience Yamaguchi University Graduate School of Medicine Ube Japan

Department of Neurology Graduate School of Medicine The University of Tokyo Tokyo Japan

Department of Rheumatology and Applied Immunology Faculty of Medicine Saitama Medical University Saitama Japan

Department of Rheumatology and Clinical Immunology Kyoto University Graduate School of Medicine Kyoto Japan

Department of Rheumatology Endocrinology and Nephrology Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan

Department of Rheumatology Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University Tokyo Japan

Division of Population Health Health Services Research and Primary Care School of Health Sciences Faculty of Biology Medicine and Health Centre for Integrated Genomic Medical Research Manchester Academic Health Science Centre University of Manchester Manchester UK

Division of Rheumatic Diseases National Center for Global Health and Medicine Tokyo Japan

Division of Rheumatology Department of Internal Medicine Hyogo College of Medicine Hyogo Japan

Division of Rheumatology Department of Internal Medicine Keio University School of Medicine Tokyo Japan

Institute of Rheumatology Charles University Prague Czech Republic

Institute of Rheumatology Tokyo Women's Medical University Tokyo Japan

Laboratory for Autoimmune Diseases RIKEN Center for Integrative Medical Sciences Yokohama Japan

Laboratory for Autoimmune Diseases RIKEN Center for Integrative Medical Sciences Yokohama Japan Department of Allergy and Rheumatology Graduate School of Medicine the University of Tokyo Tokyo Japan

Laboratory for Disease Systems Modeling RIKEN Center for Integrated Medical Sciences Yokohama Japan

Laboratory for Genotyping Development RIKEN Center for Integrative Medical Sciences Yokohama Japan

Laboratory for Statistical Analysis RIKEN Center for Integrative Medical Sciences Yokohama Japan

MRC ARUK Institute for Ageing and Chronic Disease University of Liverpool Liverpool UK Division of Population Health Health Services Research and Primary Care School of Health Sciences Faculty of Biology Medicine and Health Centre for Integrated Genomic Medical Research Manchester Academic Health Science Centre University of Manchester Manchester UK

Rheumatology Department Manchester Academic Health Science Centre Salford Royal NHS Foundation Trust Salford UK The National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit Central Manchester University Hospitals NHS Foundation Trust Manchester Academic Health Science Centre The University of Manchester Manchester UK

The 1st Department of Internal Medicine University of Occupational and Environmental Health Kitakyushu Japan

The National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit Central Manchester University Hospitals NHS Foundation Trust Manchester Academic Health Science Centre The University of Manchester Manchester UK

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012915
003      
CZ-PrNML
005      
20200206075731.0
007      
ta
008      
190405s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/annrheumdis-2017-212149 $2 doi
035    __
$a (PubMed)29331962
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kochi, Yuta $u Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
245    10
$a Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis / $c Y. Kochi, Y. Kamatani, Y. Kondo, A. Suzuki, E. Kawakami, R. Hiwa, Y. Momozawa, M. Fujimoto, M. Jinnin, Y. Tanaka, T. Kanda, RG. Cooper, H. Chinoy, S. Rothwell, JA. Lamb, J. Vencovský, H. Mann, K. Ohmura, K. Myouzen, K. Ishigaki, R. Nakashima, Y. Hosono, H. Tsuboi, H. Kawasumi, Y. Iwasaki, H. Kajiyama, T. Horita, M. Ogawa-Momohara, A. Takamura, S. Tsunoda, J. Shimizu, K. Fujio, H. Amano, A. Mimori, A. Kawakami, H. Umehara, T. Takeuchi, H. Sano, Y. Muro, T. Atsumi, T. Mimura, Y. Kawaguchi, T. Mimori, A. Takahashi, M. Kubo, H. Kohsaka, T. Sumida, K. Yamamoto,
520    9_
$a OBJECTIVES: Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of rare autoimmune diseases in which both genetic and environmental factors play important roles. To identify genetic factors of IIM including polymyositis, dermatomyositis (DM) and clinically amyopathic DM (CADM), we performed the first genome-wide association study for IIM in an Asian population. METHODS: We genotyped and tested 496 819 single nucleotide polymorphism for association using 576 patients with IIM and 6270 control subjects. We also examined the causal mechanism of disease-associated variants by in silico analyses using publicly available data sets as well as by in in vitro analyses using reporter assays and apoptosis assays. RESULTS: We identified a variant in WDFY4 that was significantly associated with CADM (rs7919656; OR=3.87; P=1.5×10-8). This variant had a cis-splicing quantitative trait locus (QTL) effect for a truncated WDFY4isoform (tr-WDFY4), with higher expression in the risk allele. Transexpression QTL analysis of this variant showed a positive correlation with the expression of NF-κB associated genes. Furthermore, we demonstrated that both WDFY4 and tr-WDFY4 interacted with pattern recognition receptors such as TLR3, TLR4, TLR9 and MDA5 and augmented the NF-κB activation by these receptors. WDFY4 isoforms also enhanced MDA5-induced apoptosis to a greater extent in the tr-WDFY4-transfected cells. CONCLUSIONS: As CADM is characterised by the appearance of anti-MDA5 autoantibodies and severe lung inflammation, the WDFY4 variant may play a critical role in the pathogenesis of CADM.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a alely $7 D000483
650    _2
$a apoptóza $x genetika $7 D017209
650    _2
$a Asijci $x genetika $7 D044466
650    _2
$a autoprotilátky $x genetika $7 D001323
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a dermatomyozitida $x genetika $7 D003882
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a celogenomová asociační studie $7 D055106
650    _2
$a genotyp $7 D005838
650    _2
$a genotypizační techniky $7 D060005
650    _2
$a lidé $7 D006801
650    _2
$a IFIH1 $x genetika $x imunologie $7 D000072640
650    _2
$a intracelulární signální peptidy a proteiny $x genetika $7 D047908
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a NF-kappa B $x genetika $7 D016328
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a polymyozitida $x genetika $7 D017285
650    _2
$a protein - isoformy $x genetika $7 D020033
650    _2
$a lokus kvantitativního znaku $x genetika $7 D040641
650    _2
$a sestřih RNA $x genetika $7 D012326
650    _2
$a rizikové faktory $7 D012307
650    _2
$a signální transdukce $x genetika $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kamatani, Yoichiro $u Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
700    1_
$a Kondo, Yuya $u Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
700    1_
$a Suzuki, Akari $u Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
700    1_
$a Kawakami, Eiryo $u Laboratory for Disease Systems Modeling, RIKEN Center for Integrated Medical Sciences, Yokohama, Japan.
700    1_
$a Hiwa, Ryosuke $u Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
700    1_
$a Momozawa, Yukihide $u Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
700    1_
$a Fujimoto, Manabu $u Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan. Department of Dermatology, University of Tsukuba, Ibaraki, Japan.
700    1_
$a Jinnin, Masatoshi $u Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
700    1_
$a Tanaka, Yoshiya $u The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
700    1_
$a Kanda, Takashi $u Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Ube, Japan.
700    1_
$a Cooper, Robert G $u MRC-ARUK Institute for Ageing and Chronic Disease, University of Liverpool, Liverpool, UK. Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, Centre for Integrated Genomic Medical Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
700    1_
$a Chinoy, Hector $u Rheumatology Department, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK. The National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
700    1_
$a Rothwell, Simon $u The National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
700    1_
$a Lamb, Janine A $u Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, Centre for Integrated Genomic Medical Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
700    1_
$a Vencovský, Jiří $u Institute of Rheumatology, Charles University, Prague, Czech Republic.
700    1_
$a Mann, Heřman, $d 1973- $7 nlk20010095506 $u Institute of Rheumatology, Charles University, Prague, Czech Republic.
700    1_
$a Ohmura, Koichiro $u Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
700    1_
$a Myouzen, Keiko $u Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
700    1_
$a Ishigaki, Kazuyoshi $u Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
700    1_
$a Nakashima, Ran $u Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
700    1_
$a Hosono, Yuji $u Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
700    1_
$a Tsuboi, Hiroto $u Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
700    1_
$a Kawasumi, Hidenaga $u Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
700    1_
$a Iwasaki, Yukiko $u Department of Allergy and Rheumatology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
700    1_
$a Kajiyama, Hiroshi $u Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
700    1_
$a Horita, Tetsuya $u Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
700    1_
$a Ogawa-Momohara, Mariko $u Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
700    1_
$a Takamura, Akito $u Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
700    1_
$a Tsunoda, Shinichiro $u Division of Rheumatology Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.
700    1_
$a Shimizu, Jun $u Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
700    1_
$a Fujio, Keishi $u Department of Allergy and Rheumatology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
700    1_
$a Amano, Hirofumi $u Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.
700    1_
$a Mimori, Akio $u Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan.
700    1_
$a Kawakami, Atsushi $u Department of Immunology and Rheumatology, Unit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
700    1_
$a Umehara, Hisanori $u Department of Hematology and Immunology, Kanazawa Medical University, Ishikawa, Japan.
700    1_
$a Takeuchi, Tsutomu $u Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
700    1_
$a Sano, Hajime $u Division of Rheumatology Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.
700    1_
$a Muro, Yoshinao $u Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
700    1_
$a Atsumi, Tatsuya $u Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
700    1_
$a Mimura, Toshihide $u Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
700    1_
$a Kawaguchi, Yasushi $u Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
700    1_
$a Mimori, Tsuneyo $u Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
700    1_
$a Takahashi, Atsushi $u Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
700    1_
$a Kubo, Michiaki $u Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
700    1_
$a Kohsaka, Hitoshi $u Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
700    1_
$a Sumida, Takayuki $u Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
700    1_
$a Yamamoto, Kazuhiko $u Laboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. Department of Allergy and Rheumatology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
773    0_
$w MED00000444 $t Annals of the rheumatic diseases $x 1468-2060 $g Roč. 77, č. 4 (2018), s. 602-611
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29331962 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20200206080120 $b ABA008
999    __
$a ok $b bmc $g 1392225 $s 1051220
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 77 $c 4 $d 602-611 $e 20180113 $i 1468-2060 $m Annals of the rheumatic diseases $n Ann Rheum Dis $x MED00000444
LZP    __
$a Pubmed-20190405

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...